“The new “Seegnal Point of Care” solution allows ADSCC’s physicians and pharmacists to provide, on the one hand, patient-tailored safe and efficient medication prescription, taking into consideration hundreds of patient-specific factors when analyzing the medication regime, and on the other hand, eradicate any potential adverse drug effects setting up a new bar for patient safety in the region.”

– Dr. Fatima Al Kaabi, Executive Director, Abu Dhabi Bone Marrow Transplant Program

“The Seegnal DRP solution packs intelligence, usability, and personalized medical treatment, delivering capabilities and benefits unseen before. Seegnal’s ability to incorporate hundreds of patient-specific parameters and immediately present patient-tailored DRP alerts is unique. The user-friendly graphic interface is adjustable to suit the clinician’s preference. We believe that patient-specific medicine should be a standard in patient care”

– Dr. Shira Greenfeld, Director of Clinical Informatics, MHS

“In summary, I can wholeheartedly endorse the Seegnal POC and believe that its implementation in health care systems, both in hospitals and ambulatory care, will greatly reduce the rate of drug-related problems and medication errors and thus improve the safety and effectiveness of medication therapy.”

– Professor Daniel Kurnik, MD, Director, Section of Clinical Pharmacology and Toxicology, Rambam Health Care Campus 

“Thanks to the system's capability to alert pharmacogenetic factors in drug treatment selection, we became the first to map several key genes related to drug response in about a thousand patients. Recently, we published two articles analyzing the impact of these findings, which support integrating pharmacogenetic data to enhance personalized treatment, potentially reducing side effects and improving patient outcomes.”

Prof. Shlomo Vinker, Head of Medical Division, Leumit Health Services